Glaucoma is often called the “thief of sight” for a chilling reason: it develops slowly, without pain, and often without symptoms until irreversible damage is already done. As we observe World Glaucoma Week (March 8–14, 2026), the theme “Uniting for a Glaucoma-Free World” takes on a new level of urgency.
By 2040, an estimated 112 million people worldwide will be living with this condition—with the highest burden falling on Africa and Asia. However, groundbreaking research from Wits University is finally shedding light on why this disease is so aggressive in African populations and how we might stop it.
The African Context: Why Timing is Everything
According to Dr. Susan Williams, a senior lecturer at Wits and head of the glaucoma unit at Charlotte Maxeke Johannesburg Academic Hospital, the most common form—Primary Open-Angle Glaucoma (POAG)—presents unique challenges for those of African descent:
- Earlier Onset: The disease typically starts at a younger age compared to other populations.
- Faster Progression: It moves more aggressively toward blindness.
- Higher Prevalence: Approximately 4.2% of Africans between ages 40 and 80 are affected.
The Genetic Breakthrough: The “Alzheimer’s Link”
Most genetic studies on glaucoma have historically focused on European populations. However, the Genetics of Glaucoma in People of African Descent Consortium recently analyzed data from nearly 10,000 patients and found a game-changing association:
- The APBB2 Gene: Researchers identified a variant of this gene that is exclusively found in people of African descent.
- The Amyloid Connection: This variant is linked to the buildup of amyloid, a protein toxic to brain tissue and a well-known hallmark of Alzheimer’s disease.
- New Treatment Horizons: While glaucoma and dementia are different conditions, they may share similar biological pathways of nerve damage. This means that drugs currently being developed to treat dementia could potentially be repurposed to save the sight of glaucoma patients.
Precision Medicine: The Future of Eye Care
We are moving toward an era of Precision Medicine. By identifying these genetic markers, doctors can:
- Identify high-risk patients before they lose their vision.
- Tailor treatments specifically to the biological pathways of the individual.
- Save patients from the costs and side effects of treatments that won’t work for their specific genetic makeup.
Protect Your Vision: What You Can Do Now
Currently, the only way to treat glaucoma is by reducing internal eye pressure through drops, lasers, or surgery. Because you cannot feel high eye pressure, regular screenings are your only defense.
The Golden Rule: If you are over 40, or have a family history of glaucoma, an annual optic nerve check is not optional—it is essential.
